Tricuspid Regurgitation and Implantable Devices
Why the study?
Does cardiac device implantation increase the prevalence of tricuspid regurgitation in patients receiving ICDs or PPMs?
Population
1,596 patients who had cardiac devices implanted between 2005 and 2011 at the Cleveland Clinic with at least…
Comparison
Cardiac device implantation vs Preimplantation baseline
Design
Cohort
Follow-up
median 10 months
Authors
Discussion
Loading...
Member takes
Implication
TR progression after device implantation may warrant echocardiographic monitoring; leaves open whether lead strategies alter mortality risk.
Structured PICO
Does cardiac device implantation increase the prevalence of tricuspid regurgitation in patients receiving ICDs or PPMs?
P
Population
1,596 patients who had cardiac devices (ICD or PPM) implanted between 2005 and 2011 at the Cleveland Clinic with at least one preimplantation and one postimplantation echocardiogram, mean age 60 ± 10 years, 61% men.
I
Intervention
Cardiac device implantation (implantable cardioverter defibrillator [ICD] or permanent pacemaker [PPM])
C
Comparator
Preimplantation baseline (within-patient comparison)
O
Outcome
Postimplantation tricuspid regurgitation (TR)surrogate
Cardiac device implantation is associated with a progressive increase in moderate-to-severe tricuspid regurgitation, which independently predicts late mortality.
Cite This Study
Al‐Bawardy et al. (2014) studied this question.